These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6402857)

  • 1. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
    Vox Sang; 1983; 44(1):48-64. PubMed ID: 6402857
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study.
    Aach RD; Szmuness W; Mosley JW; Hollinger FB; Kahn RA; Stevens CE; Edwards VM; Werch J
    N Engl J Med; 1981 Apr; 304(17):989-94. PubMed ID: 6782484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transfusion hepatitis: analysis of risk factors.
    Aach RD; Hollinger FB; Szmuness W; Mosley JW; Gitnick GL; Kahn RA; Stevens CE; Goodwin D; Weiner JM
    Acta Haematol Pol; 1980; 11(3):159-64. PubMed ID: 6778053
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor serum alanine aminotransferase activity and the risk of transfusion-associated hepatitis.
    Lenes BA; Tomasulo P; Alter HJ; Holland PV
    N Engl J Med; 1983 Mar; 308(12):723. PubMed ID: 6402702
    [No Abstract]   [Full Text] [Related]  

  • 5. Post-transfusion viral hepatitis and the TTVS.
    Holland PV; Bancroft W; Zimmerman H
    N Engl J Med; 1981 Apr; 304(17):1033-5. PubMed ID: 6782483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transfusional non-A, non-B hepatitis].
    Habibi
    Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):63-70. PubMed ID: 3149551
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
    Seidl S
    Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
    [No Abstract]   [Full Text] [Related]  

  • 8. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors.
    N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN; Perkins HA
    N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
    [No Abstract]   [Full Text] [Related]  

  • 10. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G; Cambiè G; D'Agostino F; Sterza G
    Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood.
    Katchaki JN; Siem TH; Brouwer R
    N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incidence of an antigen/antibody system characterizing 1 subgroup of posttransfusion non-A, non-B hepatitis].
    Renger FG; Raabe A; Forster H; Knot E
    Vutr Boles; 1986; 25(5):62-4. PubMed ID: 2433838
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-transfusion non-A, non-B hepatitis.
    Norkrans G
    Chemioterapia; 1987 Jun; 6(2 Suppl):642-3. PubMed ID: 3151355
    [No Abstract]   [Full Text] [Related]  

  • 14. Posttransfusion hepatitis: clinical features, risk and donor testing.
    Alter HJ
    Prog Clin Biol Res; 1985; 182():47-61. PubMed ID: 3929262
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of donor alanine aminotransferase testing. Implications for the blood donor and practitioner.
    Saxena S; Korula J; Shulman IA
    Arch Pathol Lab Med; 1989 Jul; 113(7):767-71. PubMed ID: 2500923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransfusion hepatitis.
    Straughn J
    Del Med J; 1988 Oct; 60(10):585-6. PubMed ID: 3143608
    [No Abstract]   [Full Text] [Related]  

  • 18. Should donor blood be screened for elevated alanine aminotransferase levels? A cost-effectiveness analysis.
    Silverstein MD; Mulley AG; Dienstag JL
    JAMA; 1984 Nov 23-30; 252(20):2839-45. PubMed ID: 6436522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis.
    Steinbrecher UP; Kovacs TO; Gelly A; Tourigny M
    Clin Invest Med; 1983; 6(4):327-30. PubMed ID: 6671363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ways of post-transfusion hepatitis prevention.
    Pintera J
    Czech Med; 1989; 12(3):149-57. PubMed ID: 2509173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.